1995
DOI: 10.1002/jnr.490400506
|View full text |Cite
|
Sign up to set email alerts
|

Effects of verapamil on the release of different neurotransmitters

Abstract: The effect of verapamil on resting and depolarization-induced monoamine release was investigated in rat hippocampal synaptosomes prelabeled with [3H]-5-hydroxytryptamine (HT) or [3H]-norepinephrine (NE) and rat striatal synaptosomes prelabeled with [3H]-dopamine (DA). Verapamil (50 microM) completely abolishes high K(+)-induced [3H]-NE release, but paradoxically facilitates high K(+)-induced [3H]-5-HT and [3H]-DA release. All these high K(+)-evoked responses were Ca2+ dependent. Verapamil does not modify [3H]-… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
6
0

Year Published

1995
1995
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 16 publications
(6 citation statements)
references
References 34 publications
0
6
0
Order By: Relevance
“…The release is dose dependent and mediated by presynaptic receptors. This increase in endogenous 5-HT is independent of the presence of external calcium [60]. Serotonin activates 5-HT 1A receptors to produce an antidepressant effect [61].…”
Section: Discussionmentioning
confidence: 99%
“…The release is dose dependent and mediated by presynaptic receptors. This increase in endogenous 5-HT is independent of the presence of external calcium [60]. Serotonin activates 5-HT 1A receptors to produce an antidepressant effect [61].…”
Section: Discussionmentioning
confidence: 99%
“…At 10 μM verapamil (for 5 min) increases endogenous dopamine release by 70% independently on the presence of external Ca 2+ . [341] According DrugMatrix in vitro pharmacology data [325] verapamil inhibits dopamine D 3 receptor in radioligand binding assay with [ 3 H]spiperone as radioligand with K i of 63 nM; human B max due to the verapamil, with the decrease being notably more extreme in the hippocampus. However, there was no evidence from in vitro experiments that verapamil had a direct effect on the brain benzodiazepine receptors.…”
Section: Verapamil Potassium Channels Blockingmentioning
confidence: 99%
“…At 10 μM verapamil (for 5 min) increases endogenous dopamine release by 70% independently on the presence of external Ca 2+ . [ 341 ] According DrugMatrix in vitro pharmacology data [ 325 ] verapamil inhibits dopamine D 3 receptor in radioligand binding assay with [ 3 H]spiperone as radioligand with K i of 63 nM; human H 2 ‐receptor in [ 125 I]aminopotentidine radioligand binding assay with K i of 2547 nM.…”
Section: The Most Well‐studied Multitarget Drugs With Linked Biaromat...mentioning
confidence: 99%
“…It has a similar final effect as β blockers, and shares this effect with antidepressant drugs. Working on different types of calcium entry, verapamil blocks the prejunctional α 2 receptors, which leads to an increase in NA release 18 . Verapamil may have direct catecholamine releasing effects, as it interacts with catecholamine storage vesicles in a way that reduces their ability to take up and store catecholamine, and thereby increasing NA release from sympathetic nerves 17 .…”
Section: Table 1: Effects Ofmentioning
confidence: 99%